Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Community

Get the Facts About Gaucher Disease with No-Cost Genetic Screening (Sponsored)

Gaucher (pronounced go-SHAY) disease is a genetic disorder that can have serious consequences for the brain, bones, spleen and liver. The disease is quite rare, but the carrier gene is not. 1 in 10 Ashkenazi Jews is a carrier of the gene that causes Gaucher disease.

This is why genetic screening is so critical. It’s important to consider the possibility of passing the gene on to your children. Genetic screening is an easy way to find out your personal genetic information and understand any risks associated with carrying a genetic disease.

From now through December 31, the National Gaucher Foundation (NGF) and JScreen are offering genetic screening for Gaucher and more than 100 additional genetic diseases. The screening is fully confidential and will not cost you anything. If it turns out you’re a carrier, you’ll be able to get genetic counseling too.

Here’s how it works:

1) Request a kit. Click here to go to the NGF website, where you can request your JScreen kit. (You must be between the ages of 18 and 45.)
2) Collect your sample. JScreen’s “spit kit” provides a tube for collecting a saliva sample in the privacy of your own home. The whole process takes two to five minutes.
3) Send it in. The kit comes with a prepaid FedEx envelope, so sending it to the lab is easy.
4) Get the results. JScreen’s lab at Emory University will analyze your DNA within four weeks of receiving your kit. A licensed genetic counselor will then follow up with you regarding your results, and be able to provide confidential and personalized guidance.

Even if you’ve had genetic screening before, you should do it again: “We recommend that people get screening updates because with each subsequent panel screening changes,” says Karen Grinzaid, a genetic counselor and the director of JScreen.

If you have more questions, visit gaucherdisease.org/screening or call 800-925-8885.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version